In VivoGene Therapy for Prostate Cancer: Preclinical Evaluation of Two Different Enzyme-Directed Prodrug Therapy Systems Delivered by Identical Adenovirus Vectors-Reference-Cited by-同舟云学术

In VivoGene Therapy for Prostate Cancer: Preclinical Evaluation of Two Different Enzyme-Directed Prodrug Therapy Systems Delivered by Identical Adenovirus Vectors

Published:1998-07-20 Issue:11 Volume:9 Page:1617-1626
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Martiniello-Wilks Rosetta,Garcia-Aragon Juanita,Daja Mirella M.,Russell Peter,Both Gerald W.,Molloy Peter L.,Lockett Linda J.,Russell Pamela J.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.1998.9.11-1617

Reference54 articles.

1. Inhibition of Melanoma Growth by Adenoviral-Mediated HSV Thymidine Kinase Gene Transfer In Vivo

2. Cancer statistics, 1994

3. Relative activity and specificity of promoters from prostate-expressed genes

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microbial cytosine deaminase is a programmable anticancer prodrug mediating enzyme: antibody, and gene directed enzyme prodrug therapy;Heliyon;2022-09

2. Intratumoral generation of 2‐fluoroadenine to treat solid malignancies of the head and neck;Head & Neck;2019-01-11

3. Use of E. coli Purine Nucleoside Phosphorylase in the Treatment of Solid Tumors;Current Pharmaceutical Design;2018-02-16

4. Application of Synthetic Tumor-Specific Promoters Responsive to the Tumor Microenvironment;Methods in Molecular Biology;2017

5. Progress and problems with the use of suicide genes for targeted cancer therapy;Advanced Drug Delivery Reviews;2016-04